Concepedia

John Mendlein

JM

Statistics

Publications

14

Citations

1.2K

H-Index

13

Active since

1983

Affiliations

aTyr Pharma (United States)(Current)

University of Hong Kong

Scripps Research Institute

Hong Kong University of Science and Technology

University of California, Los Angeles

John Mendlein is an author at aTyr Pharma (United States) specializing in life sciences, biochemistry, and enzymology.

Publications per year

1983–2019

14

Publications

14

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation

Corey Cutler, Pratik S. Multani, David Robbins et al. · Blood · 2013 · 303 citations · Full text

Medicine, Hematology, Surgery +10

Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.

B. Wallmark, Carin Briving, J. Fryklund et al. · Journal of Biological Chemistry · 1987 · 232 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Human tRNA synthetase catalytic nulls with diverse functions

Wing‐Sze Lo, Elisabeth Gardiner, Zhiwen Xu et al. · Science · 2014 · 124 citations

Life Sciences, Biochemistry, Molecular Biology +12

Interaction of fluorescein isothiocyanate with the (H+ + K+)-ATPase

R J Jackson, John Mendlein, George Sachs · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1983 · 89 citations

Life Sciences, Biochemistry, Biophysics +10

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

Roni Mamluk, Irvith M. Carvajal, Brent Morse et al. · mAbs · 2010 · 80 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 14